# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001549595-26-000040
Filing Date
2026-07-09
Accepted
2026-07-09 16:12:07
Documents
69
Period of Report
2026-05-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | nrix-20260531.htm iXBRL | 10-Q | 1488642
2 | EX-10.2 | nrix-20260531xxex102amendn.htm | EX-10.2 | 63786
3 | EX-31.1 | nrix-20260531x10qxex311.htm | EX-31.1 | 10676
4 | EX-31.2 | nrix-20260531x10qxex312.htm | EX-31.2 | 10666
5 | EX-32.1 | nrix-20260531x10qxex321.htm | EX-32.1 | 8281
| Complete submission text file | 0001549595-26-000040.txt |  | 6702163

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | nrix-20260531.xsd | EX-101.SCH | 44985
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | nrix-20260531_cal.xml | EX-101.CAL | 53255
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | nrix-20260531_def.xml | EX-101.DEF | 222675
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | nrix-20260531_lab.xml | EX-101.LAB | 586673
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | nrix-20260531_pre.xml | EX-101.PRE | 394108
73 | EXTRACTED XBRL INSTANCE DOCUMENT | nrix-20260531_htm.xml | XML | 714363

Mailing Address 1600 SIERRA POINT PKWY BRISBANE CA 94005
Business Address 1600 SIERRA POINT PKWY BRISBANE CA 94005 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

EIN.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 001-39398 | Film No.: 261165801
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)